---
title: "Numinus Refocuses on Psychedelic Clinical Research Amid Audit and TSX Delisting Review"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279100246.md"
description: "Numinus Refocuses on Psychedelic Clinical Research Amid Audit and TSX Delisting Review"
datetime: "2026-03-13T23:38:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279100246.md)
  - [en](https://longbridge.com/en/news/279100246.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279100246.md)
---

# Numinus Refocuses on Psychedelic Clinical Research Amid Audit and TSX Delisting Review

Numinus Refocuses on Psychedelic Clinical Research Amid Audit and TSX Delisting Review

### Related Stocks

- [NEPTF.US](https://longbridge.com/en/quote/NEPTF.US.md)
- [AYRWF.US](https://longbridge.com/en/quote/AYRWF.US.md)

## Related News & Research

- [This stock is a backdoor play on the SpaceX IPO—and it has plenty more upside](https://longbridge.com/en/news/286924869.md)
- [Cerebras Just Rocketed Onto the Nasdaq. The Biggest IPO of 2026 Isn’t a Buy Here.](https://longbridge.com/en/news/286918115.md)
- [Spire Global Selected by Amadeus for Real-Time Aircraft Tracking Data Integration | SPIR Stock News](https://longbridge.com/en/news/286897250.md)
- [Financial services roundup: Market talk](https://longbridge.com/en/news/287054197.md)
- [US 30-year Treasury yield could rise above 6%, BofA survey says](https://longbridge.com/en/news/286894243.md)